The effect of entacapone on homocysteine levels in Parkinson disease.
Ostrem
J L
JL
Department of Neurology, University of California, San Francisco, USA.
Kang
G A
GA
Subramanian
I
I
Guarnieri
M
M
Hubble
J
J
Rabinowicz
A L
AL
Bronstein
J
J
D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000378:metabolism; D002230:Carbidopa / Q000494:pharmacology; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000494:pharmacology* / Q000627:therapeutic use; D015331:Cohort Studies; D004347:Drug Interactions / Q000502:physiology; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006710:Homocysteine / Q000096:biosynthesis* / Q000097:blood; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy*; D007980:Levodopa / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D004791:Enzyme Inhibitors; D009570:Nitriles; D006710:Homocysteine; D007980:Levodopa; C071192:entacapone; D002394:Catechol O-Methyltransferase; D002230:Carbidopa